Ultralow doses of vasopressin in the management of diabetes insipidus.
Management of postoperative diabetes insipidus (DI) frequently requires intermittent treatment with multiple subcutaneous injections of pituitrin or vasopressin, in doses averaging 20 IU/24 h. Use of a syringe pump for a continuous infusion of ultralow doses of pituitrin produced uniform, constant, and sustained reduction of urinary output, thus facilitating regular fluid replacement. Twelve patients with postoperative DI received iv pituitrin at a dose of 1.6 +/- 0.26 mIU/kg X h (1 to 2 IU/24 h). The antidiuretic effect began at the third hour of treatment, peaked by the sixth hour (diuresis of 37 ml/h, specific gravity of 1.018 +/- 0.002), and was sustained throughout infusion. Polyuria recurred 3 h after the infusion was discontinued; this rapid reversibility is highly advantageous when excessive fluid intake causes overhydration. Pressor effects were not observed during the treatment period.
D000293:Adolescent; D000328:Adult; D002648:Child; D003397:Craniopharyngioma / Q000601:surgery; D003919:Diabetes Insipidus / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology / Q000652:urine; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D010909:Pituitary Hormones, Posterior / Q000008:administration & dosage*; D010911:Pituitary Neoplasms / Q000601:surgery; D011183:Postoperative Complications
D010909:Pituitary Hormones, Posterior